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Objective: to study the histopathological characteristics of prosthetic vascular graft infection. 
Design: prospective clinical study over 2 years. 
Setting: University Hospital. 
Materials: 36 infected and 29 uninfected (control) chronically implanted vascular prostheses (half aortic) were removed 
and 352 sections prepared. 
Chief outcome measures: light microscopy (multiple stains), scanning electron microscopy (SEM), and multiple culture 
techniques to identify characteristics of healing, infection, and microorganisms. 
Main results: Acute inflammation (AI) (neurophils, granulocytes and necrosis) were seen in 75% of infected grafts, were 
most prominent in the perigraft issue and rarely seen on the luminal surface. These were usually well locaUsed, leaving 
the remainder of a graft well incorporated with no signs of infection. In 25% of clinically infected, culture-positive grafts 
there was no sign~cant acute inflammation. Chronic inflammation (CI) (macrophages, lymphocytes, monocytes, giant 
cells) was seen in 70% of both control and infected grafts. In 50% of both groups a significant lymphocytic population was 
composed exclusively of T-lymphocytes suggesting a true host vs. graft response. Unincorporated chronically implanted 
grafts (> 1 yr) were seen with equal frequency in the two groups although more diffusely unincorporated grafts were 
infected. Microorganisms were cultured from 23 infected grafts (64%) and were, at microscopy, mostly found outside the 
graft and nerves on the luminal side. 
Conclusions: This data cast doubt on criteria commonly used to distinguish graft infections and host vs. graft reactions 
from normal graft healing. Acute and chronic inflammation are not predictive of infection. 
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Introduction 
Prosthetic vascular grafts have revolutionised the 
surgical treatment of occlusive and aneurysmal dis- 
ease in the last three decades. Despite their enviable 
record, a spectrum of healing complications has been 
evident since the first human use of these grafts. These 
complications include acute and chronic perigraft 
infection, seroma formation, anastomotic failure, and 
prosthetic-enteric erosion. They occur in 1-6% of 
patients following successful graft implantation, 1-3 
pose a serious threat to the life and limbs of the 
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patient, and demand innovative treatment for their 
solution. Significant improvement in the surgical 
management of these problems has occurred over the 
last two decades, but understanding oftheir cause and 
clinical evolution remains limited. Although there 
have been a substantial number of experimental 
studies in non-human animals, there have been few 
human studies following prosthetic graft implantation 
that carefully evaluate the healing or incorporation 
process of the prosthetic implant itself. While the 
vascular surgeon has been concerned with improving 
the results of treatment for threatened patients, the 
lack of concerted efforts to define human prosthetic 
graft healing offer little hope of preventing these 
dreaded complications in the foreseeable future. 
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Materials and Methods 
The present prospective study examines the histologic 
characteristics of human prosthetic arterial grafts from 
infected and non-infected explants. During a 2-year 
period, 1987-88, 65 consecutive explanted prostheses 
were studied prospectively b  microbiological culture, 
and light and scanning electron microscopy. Thirty-six 
grafts (27 Dacron, seven PTFE, two Dacron/PTFE) 
were considered clinically infected when cultures of 
the graft were positive and/or the graft was poorly 
incorporated by fibrous tissue, and/or surrounded by 
fluid or pus. Twenty-nine grafts (16 Dacron, 12 PTFE, 
one Dacron/PTFE) served as controls being explanted 
for non-infectious reasons (23 thrombosis, six revi- 
sions for stenosis, pseudo- or anastomotic aneurysms). 
After explantation, each graft was immediately pre- 
pared for microbiological cultures and cut in a 
standardised fashion. A total of 249 sections of 
infected and 103 sections of control grafts were 
evaluated. Another 11 sections of infected and five 
sections of control grafts were excluded because of 
unsatisfactory preparation. 
Light microscopy 
Representative sections of graft and surrounding 
tissue were fixed in formalin, embedded in paraffin, 
cut into 5 vm sections, and then stained with the 
following stains: 
Hematoxylin-eosin (H & E) was used to evaluate the 
overall architecture of tissue, presence of acute and 
chronic inflammatory cells (neutrophils, lympho- 
cytes, monocytes or macrophages, giant cells) peri- 
graft necrosis, fibrin deposition or scarring (incor- 
poration), and presence of fungal or clusters of 
bacterial organisms. 
Trichrome (connective tissue stain) was used to 
determine the degree of fibrous incorporation. 
Brown and Brenn (Gram stain) was used for the 
identification ofGram positive, Gram negative, and 
fungal organisms. 
In addition, representative s ctions of fresh graft and 
surrounding tissues from selected cases were also 
fixed in paraformaldehyde, embedded in glycolme- 
thacrylate, and then stained using PAP (immunohis- 
tochemical) technique with Leu-4 and Pan-B antisera 
to classify the lymphocyte population in the tissues 
into Type T and B types respectively. 
The following classifications were used in this study: 
Acute inflammation - -  the presence of neutrophils, 
granulocytes, and perigraft issue necrosis defined 
acute inflammation. 
Chronic inflammation - -  the presence of mono- 
cytes, macrophages, lymphocytes and giant cells 
indicated the presence of chronic inflammation 
and/or foreign body reaction. 
Incorporation - -  incorporation was evaluated by 
determining the extent of collagenous carring in 
the perigraft tissue and in the graft wall itself using 
both the H & E and trichrome stains. Fibrin deposi- 
tion and necrosis indicated lack of incorporation 
while scar formation around the graft indicated the 
presence of incorporation. 
The development ofpseudoinitima (scar or clot lining 
the luminal side of the graft) was also noted. 
Grading 
All specimens were examined blindly by the same 
pathologist and graded according to an arbitrary scale, 
0-3. A double test of this grading system revealed less 
than 10% variability. Cellular infiltration was graded 
as follows: 0 -- no inflammatory cell response; 1 --- 
scattered, scant inflammatory cells; 2 -- irregular 
spread clusters; 3 = sheets or extensive confluent 
infiltration. 
Perri-graft Collagenisation 
0 no collagen 
1 scattered, scant collagen bands 
2 small sheets to aggregates - -  discontinuous, 
thickness on outside smaller than that of graft 
3 extensive scarring - -  continuous, thickness 
more than that of graft 
Collagenisation i graft wall 
0 no collagen 
1 less than 30% of graft interstices 
2 discontinuous, but more than 30% 
3 extensive between all graft fibers 
Pseudointima 
0 no pseudointima 
1 discontinuous, thickness less than 30% of graft 
wall 
2 continuous, thickness less than 30% of graft 
wall 
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3 fully developed continuous 
when calculating the results only a grade > 2 was 10 
considered as significant regarding all these 
parameters. ~ i 
Scanning Electron Microscopy (SEM) 
2 
The special preparation required for scanning electron 
microscopy was performed by an extensively trained 0 <i ,2 -4 -6 -8 -10.12 -14.1~ 3o 
technologist who was blinded regarding the category 
of the specimen. The purpose of using SEM was to 
document he presence of microorganisms and/or  
biofilm on the surface of the grafts. SEM was per- 
formed in two steps: first, the intact surface was 
scanned and secondly, the layers covering the graft 
surface were disrupted by instrumentation a d then 
reexamined. 
In order to increase the likelihood of culturing 
slime producing bacteria the specimens were 
mechanically disrupted by grinding and then inocu- 
lated on Brucella nd thioglycolate broth plates and on 
blood/chocolate agar for growth of bacteria s well as 
fungi. 
Statistical analysis used the Student's t-test, the 
Mann-Whitney U-test and %2 analysis. 
• Infected 
[] Controls 
Years 
Fig. 1. Distribution of implantation times for explanted vascular 
grafts. 
location. Of the infected aortic grafts, 15 were primary 
graft infections and six were associated with aortoen- 
teric fistulae. The mean implantation time of the 
infected grafts was 4 years, 2 months (range 1 mo-30 
yrs) and 2 years, 9 months (range i mo-12 yrs) for the 
controls. The distribution of implantation times are 
shown in Fig. 1. 
Table 2. Distribution of acute inflammatory reaction and the 
presence of necrosis 
Acute inflammation Necrosis 
Results 
Table 1. Original implantation site of the explanted graft 
Infected Controls 
Aorto-visceral - 2 
Perigraft Graft Luminal 
tissue wall surface 
Infected 13 /36% 12 /33% 8 / 22% 21 / 58% 
(n=36) 
Controls 3/10% 1/3% 0/0% 1/3% 
(n=29) 
p 0,003 0,004 0,01 <0,001 
Aortic - 1 
AIBG 3 4 
AFBG 18 7 
Femoro-femoral 1 2 
Femoro-popliteal 3 5 
Axillo-femoral 8 - 
Innominate / subclavian 1 2 
AV fistula 2 6 
As shown in Table 1, the original sites of the explanted 
grafts were similar in the two groups with approx- 
imately half of the grafts recovered from an aortic 
Acute inflammation (Table 2) as defined by 
neutrophiles, granulocytes and/or  necrosis occurred 
in 75% of the infected grafts leaving 25% of the 
infected grafts with no histologic signs of acute 
reaction or necrosis. Of these, 66% were positive for 
microorganisms by culture and microscopy. The 
degree of acute inflammation was significantly higher 
in the perigraft tissue than on the luminal surface 
(p < 0.001). The acute inflammation and necrosis was 
very localised in some specimens with the remainder 
of the graft well incorporated and with no signs of 
infection. This is demonstrated by the fact that among 
individual sections of the infected grafts, 108 (43%) 
were graded 0 for acute inflammation/necrosis. These 
localised infections did not seem preferential in their 
locations, i.e. retroperitoneum vs. groins. As expected, 
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a comparison with the control grafts revealed sig- 
nificantly greater acute r action around the infected 
grafts. Interestingly however, 14% of the non-infected 
(control) grafts also revealed signs of significant, 
perigraft acute inflammation or necrosis. Chronic 
Table 3. Chronic inflammation and foreign body reaction 
Giant cells Lymphocytes Monocytes 
Infected 28/78% 19 /53% 24/67% 
(n=36) 
Controls 20/69% 14/48% 18 /62% 
(n=29) 
p 0.06 0.9 0.9 
inflammation (Table 3) as defined by monocyte and 
lymphocyte infiltration and the presence of macro- 
phages and giant cells (the latter representing a
foreign body reaction) was seen in the majority of, and 
in equal rates in, infected and control grafts (Fig. 2). 
Grafts with significant lymphocyte infiltration were 
subjected to special immunohistochernical staining 
(Leu 4, Pan B) to classify the lymphocytes. The 
lymphocyte population was in all instances almost 
exclusively made up of T-lyrnphocytes (Fig. 3) Seventy 
percent of all grafts showed significant histologic 
reaction in at least one of the parameters of chronic 
inflammation. Graft healing or incorporation (Table 4) 
as determined by fibrin deposition, collagenisation i
the perigraft issue and in the graft wall itself revealed 
no difference between infected and control grafts. 
However, the development of pseudointima was 
significantly better in the infected grafts. 
The following subgroups were statistically corn- 
Fig. 3. Light microscopy (Leu-4, Pan-B) of an infected PTFE graft 
with mild-moderate chronic i flammation and T-lymphocyte 
infiltration (arrows). 
pared with no statistically significant differences being 
identified: positive vs .  negative for the presence of 
microorganisms by culture and/or microscopy, 
implantation time (more vs .  less than 2 years), and 
type of graft material (Dacron vs .  PTFE). It is also 
noteworthy that obvious graft disruption was found 
in one of the infected grafts (Dacron) but in two of the 
controls (one Dacron, one PTFE), none of which had 
been used for vascular access. All control grafts were 
uninfected using the criteria of the absence ofbacteria 
or fungi by culture or microscopy. Sixty-four percent 
of the cultures from infected grafts were positive and 
36% of grafts had bacteria or fungi revealed by 
microscopy. In Table 5, an overview of the microbio- 
logic assessment is given. When the presence of 
bacteria was demonstrated by microscopy they were 
abundant in the outer parts of the graft wall and never 
seen on the luminal surface (Fig. 4). A total of 10 (28%) 
of the infected grafts were negative for microorgan- 
isms by both of the described methods. Eight or 22% 
of infected grafts were positive for fungus by culture 
or microscopy, six of which also had bacterial growth. 
The different strains grown at culture are listed in 
Table 6. 
Fig. 2. Light microscopy ( H & E stain) of a non infected Dacron graft 
explanted 3 years after implantation with a very strong chronic 
inflammatory/foreign body reaction with giant cell (arrowheads) 
engulfing raft material (arrow). 
Table 4. Incorporation 
Scarring Scarring in Pseudointima 
perigraft graft wall 
Infected 27 /75% 27 /75% 30 /83% 
(n=36) 
Controls 22 /61% 17/47% 13 /36% 
(n=29) 
p 0.3 0.3 0.003 
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Table 5. The presence of microorganisms in the infected grafts 
was revealed by culture or microscopy alone or in combination 
Culture Microscopy Cx / Micro 
Bacteria 12 2 4 
Fungus 1 - 1 
Bact / Fungi - 1 5 
Total 13 3 10 
Fig. 4. Light microscopy (Gram-stain) of an infected PTFE graft with 
lots of bacterial clusters (arrows) in the outer half of the graft wall (A 
= outside graft) but none in the luminal side (= B). 
Bacteria were expected to occur in clusters of 
rounded bodies of equal size. Despite exhaustive 
electron microscopy, only one possible bacterial dus- 
ter was found. Other rounded bodies, easily mistaken 
for bacteria, were seen but did not fulfill the require- 
ments for classification as bacteria and are derived 
from fragmentation f other cells like platelets and red 
blood cells (Fig. 5a, b). There were no layers or other 
substances that could reasonably be characterised as
biofilm. There was no difference in the general 
appearance at the surface of infected vs .  control 
grafts. 
Discussion 
The implantation of prosthetic foreign bodies into 
humans is routine in vascular surgery as well as in 
many other surgical disciplines. The healing and 
incorporation of these foreign bodies is a very com- 
plex process. Perusal of the literature on biocompati- 
bility underscores the many factors and mechanisms 
that are involved in foreign body reactions. The basic 
material itself, additives used during its manufactur- 
ing process, porosity, shape, size, movement of the 
graft, mechanical fatigue, and location are all factors 
that have been shown to affect the reaction in, on, and 
around a foreign body. In addition to activating the 
coagulation cascade, prosthetic grafts (devices) have 
also been shown to initiate haemolysis, activate 
complement as well as leukocytes which in turn 
release large numbers of highly active proteolytic 
enzymes. 4-6 Dacron, as used in vascular grafts, has 
also been shown to decrease the regenerative capacity 
of arteries. 7 Very recentl3~ even acute allergic reactions 
with anaphylaxis have been reported after placement 
of a vascular graft. 8
The long-term healing response and fibrous incor- 
poration of arterial prostheses in humans is not 
understood in detail. The basis for our current 
understanding and use of these devices is the assump- 
tion that what has been found in animals is also valid 
in humans. However, healing responses in different 
animal species are extremely variable. There are also 
methodologic questions and problems in how to 
properly study these reactions. Microscopy of the 
perigraft issue and, when applicable, the graft itself 
seems to be one of the most frequently used and most 
appropriate methods. 9 Animal studies have shown 
that after an initial acute inflammatory eaction lasting 
Table 6. Microorganisms grown at culture of infected vascular 
grafts 
Microorganism Number 
S. aureus 5 
Enterococcus 5 
Pseudomonas 5 
Candida albicans 5 
S. epidermidis 4 
E. coli 4 
Bacteroides fragilis 3 
Enterobacter cloacae 3 
Serratia marc 2 
Xantomonas 1 
Proteus 1 
Klebsiella pneumoniae 1 
Streptococcus viridans 1 
Proprioni bacteria 1 
Torulopsis glabrata 1 
Multibacterial 13 
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Fig. 5. (a) SEM (magnification 9400) showing acluster of bacteria 
(arrows) in the pseudointima of n infected Dacron vascular 
graft. (b) SEM (magnification 7200) of an infected PTFE graft 
showing autolysis and fragmentation of a red blood cell (rbc) 
producing scattered rounded bodies (arrows) that could easily be 
mistaken for bacteria. 
from several days to 1-2 months, a chronic inflamma- 
tory reaction emerges. This is associated with fibro- 
blast infiltration of the perigraft space and graft 
interstices and is of importance for the initial healing 
process which eventually leads to graft incorporation 
as the fibrosis matures. The normal timespan for 
complete graft incorporation in animals has been 
estimated to be from a few weeks to 1 year. 4-6 In 
humans, it has been stated that this process could be 
completed by 3 months after graft implantation. 
Graft complications in humans appear to be 
related to impaired healing and/or the inflammatory 
reactions to foreign bodies. For example, orthopedic 
• prostheses are thought to be loosened by chronic 
inflammation. Sutures in a wound enhance the inflam- 
matory reaction and greatly potentiate the ability of 
bacteria to produce infection. The present data shows 
that substantial acute and/or chronic inflammatory 
reaction exists around most, if not all implanted 
arterial prosthetic grafts in humans. It can be con- 
cluded from many previous studies that a foreign 
body reaction, like that described here, predisposes to
infection, s'6 Published reports on human vascular 
grafts and graft related complications first appeared in 
the 1950s. Graft infections were first described and 
later reports of possible graft reactions or rejections 
appeared. 1-3" ~°-13It is possible that at least some of the 
culture-negative graft infections reported by us and 
others are really non-infected grafts with surrounding 
reactions. Dilatation and degradation ofDacron grafts 
have also been reported and can hypothetically be 
explained by the effects of tissue and proteolytic 
enzymes on the prosthetic material. 14 
There is general agreement regarding the clinical 
significance of chronic vascular graft infection, espe- 
cially aortic grafts. There is far less agreement regard- 
ing the cause of this disasterous complication. These 
infections are indeed very puzzling considering their 
very delayed presentation and the relatively high 
percentage of sterile microbiological cultures obtained 
from clinically infected specimens. We do not know if 
the infection is a primary event causing inflammation 
and separation of the graft from its perigraft capsule 
or if impaired healing is the primary response with 
chronic inflammation predisposing to infection. Fur- 
thermore, whether the infection starts on the inside of 
the graft (lumen) or in the perigraft tissue is unknown. 
Finally, it is uncertain whether or not humans can 
exert a true host-versus-graft reaction against the most 
commonly used vascular graft materials (Dacron, 
PTFE). These issues are all relevant o the present 
histopathologic data. 
Previous reports have described several patho- 
genic mechanisms for the occurrence ofgraft infection. 
Malone et al. reported that graft infection is caused by 
luminal seeding of bacteria in grafts, early after 
implantation before the development of an intact 
pseudointima, or late in grafts with incompletely 
15 17 developed pseudointima. - This concept has been 
supported by other studies, including well-docu- 
mented clinical cases, is A clinically infected vascular 
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graft is poorly incorporated within its perigraft cap- 
sule and even surrounded by pus or fluid. Yet, as 
noted earlier, it is not known if the impaired healing is 
the primary event or if it is secondary to the infection. 
The incomplete development of pseudointima,  part 
of the process of incorporation, has also been con- 
sidered important for the occurrence of graft 
infections. 
No conclusion can be made from our data on the 
importance of scarring in the perigraft tissue or in the 
graft wall. The same is true for the pseudointima 
which was even better developed in the infected grafts 
than in the non-infected control grafts. We found the 
scarring process to be non-uniform along the graft 
with a significant and comparable number of grafts in 
both groups. There was no collagenisation at all 
despite implantation times of more than 2 years. No 
significant difference in perigraft fibrosis or pseu- 
dointimal development was detected between grafts 
made of ePTFE or Dacron (we did not distinguish 
knitted from woven or velour from non-velour grafts). 
The presence of microorganisms also did not correlate 
with differences in healing. Consequently, there were 
culture verified infections in grafts that were well 
incorporated by currently accepted criteria. 
An acute inflammatory eaction and at least some 
tissue necrosis is expected from a bacterial or fungal 
infection. 19 However, this was not a consistent finding 
among the infected grafts. In this study 25% of grafts 
revealed no histologic signs at all of acute inflamma- 
tion or necrosis, but this lack of reaction did not 
correlate with negative microbiological cultures. Pos- 
sible explanations for these findings could be that the 
acute inflammation was caused by factors other than 
microorganisms or that microorganisms might be 
incapable of exerting their inflammatory provoking 
actions. Similar findings of culture-positive but histo- 
pathologically negative infections have been reported 
recently in experimental studies by other 
investigators.20, 1 
Another interesting feature of the acute inflam- 
matory response was its distribution along the graft 
and also its cross-sectional distribution in perigraft 
tissue, graft wall and pseudointima. In some cases the 
acute inflammation and necrosis were very localised 
to short segments of the graft with no acute reaction at 
all on the rest of the graft segments. Together with the 
uneven distribution of graft healing it is possible, 
perhaps even probable, that an actual graft infection 
might be very localized. This could be an important 
consideration when planning surgical treatment since 
partial graft excision may be feasible. 22 The pre- and 
intraoperative assessment and determination of the 
extent of infection is difficult and in some situations 
impossible using current criteria and sophisticated 
technology. 
In this study, a strong chronic inflammatory 
response and foreign body reaction was seen in the 
majority of control as well as infected grafts. It is 
expected only after the immediate post implantation 
acute inflammation subsides. It accompanies the 
initial incorporation process and includes fibroblast 
infiltration of the graft. We found this chronic reaction 
persisted even in chronically implanted grafts. A 
strong chronic inflammatory response occurring sev- 
eral years after graft implantation may be considered 
"normal" or serve as a marker of incomplete incor- 
poration. We believe that the significant T-lymphocyte 
population seen in half of infected and control grafts is 
strong support for a true host versus graft reaction. 
The proposed concept that primary graft infection 
results from bacterial seeding of the luminal surface of 
the graft from the blood stream deserves close 
scrutiny. The many possible sources of blood-borne 
bacteria include peripheral wounds with lymphatic 
transport of bacteria, bacterial infection of the arterial 
wall itself or temporary bacteremias after surgical 
instrumentation a d examination. There are known to 
be variations in luminal covering by pseudointima 
and the capability of the most commonly encountered 
microorganisms ( S. aureus and S. epidermidis ) to adhere 
to exposed foreign surfaces. 23-26 However, a recent 
well designed experimental study in dogs showed 
that the primary site of infection was the perigraft 
tissue, with secondary invasion of the graft wall and 
finally the luminal lining. 27 Our findings strongly 
indicate that this is also true in humans. The distribu- 
tion of microorganisms found at microscopy was 
always abundant in the perigraft issue but scant or 
absent on the luminal side. Furthermore, xperimental 
studies have clearly shown that when grafts are 
infected from the luminal surface, this is accompanied 
as expected by an acute inflammatory reaction in the 
affected part of the graft. 2° In our series of human 
specimens, the acute inflammation was always (dis- 
regarding the presence or absence of microorganisms), 
most significant on the external surface of the graft in 
the perigraft tissue. It was less evident within the graft 
wall and was absent or very rare on the luminal 
surface. 
Some bacterial strains are known to produce a 
slime layer in culture. For example, in vitro some 
strains of S. epidermidis can envelop themselves in a 
"biofilm" of an amorphous exopolysaccharide protect- 
ing them from the host defence mechanisms a well as 
from antibiotics. 2s' 29 Electron microscopic support for 
this type of biofilm has been presented in humans 
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with infections of arterial ines and pacemaker elec- 
trodes. 3°'31 Experimental models of vascular graft 
infection using infusion of slime-producting bacteria 
have shown that in this particular setting, the biofilm 
is of importance for the development of infection. 32-34 
This concept is also very attractive in explaining some 
of  the clinical characteristics of human prosthetic 
vascular graft infections (chronicity, late onset of 
appearance, type of bacteria involved, etc.) but is of 
course relevant only regarding infections by slime- 
producing bacteria. Direct evidence for the presence of 
biofilm in human vascular graft infection has, however, 
not been presented yet. The fact that ultrasonication f 
explanted grafts gives a higher yield of positive 
cultures and that bacteria picked up from infected 
grafts in vitro can produce slime only gives indirect 
support for this concept. 32-35 Our expectations were to 
find slime layers or bacteria adhering to the luminal 
surfaces of the human explanted vascular grafts as 
previously reported in clinical and experimental stud- 
ies. Despite extensive SEM only one possible bacterial 
cluster was found in one of the infected grafts. This, 
however, is in accordance with the cross-sectional 
distribution of microorganisms found by light micros- 
copy. Consequently, our results do not provide the 
final evidence for the presence of biofilm in human 
vascular graft infection. This should be compared to 
previous tudies reporting on what is termed "biofilm 
infections" in as many as 90% of pseudoaneurysms 
and 69% of thrombosed grafts. 36 This very high yield 
of bacteria, in thrombosed grafts in particular, raises 
two questions; are these biofilm infections (= infec- 
tions with Staphylococcus epidermidis requiring ultra- 
sonication to dislodge bacteria to grow in culture 
media) a very common type of contamination of 
implanted grafts with limited importance in chronic 
graft infection; are biofilm infections of importance in 
graft thrombosis? 
In conclusion, this study shows that what we 
clinically define as a vascular graft infection, has 
histologic characteristics that are similar to non- 
infected grafts. These infections eem to be related to a 
strong chronic inflammatory reaction and foreign 
body reaction as well as a true host vs. graft reaction. 
Furthermore, by showing that vascular graft infections 
in humans seem to have their nidus in the perigraft 
tissue, it casts some doubt on what has been found in 
experimental studies regarding the etiology of this 
condition. 
Our study also raises several questions regarding 
the human tolerance for vascular graft material. What 
is the true histopathologic healing response in 
humans? Are there individual variations in this 
healing response? Are grafts merely tolerated by 
individuals with a dynamic host vs. graft response? 
Can graft material be altered to achieve even better 
healing than they do today? Can the external graft 
environment be altered to allow healing of contami- 
nated yet retained prostheses? The answers to these 
questions may allow further progress in the preven- 
tion and more effective treatment of this dreaded 
surgical complication of arterial repair. 
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